Method for rapid detection and identification of bioagents

• US 20080160512A1
• Filed: 09/21/2005
• Published: 07/03/2008
• Est. Priority Date: 03/02/2001
• Status: Active Grant

• Current Assignee: Ibis Biosciences Incorporated
• Original Assignee: ISIS Pharmaceuticals Incorporated
• Inventors: Sampath, Rangarajan, McNeil, John, Ecker, David J., Hofstadler, Steven, Griffey, Richard
• Granted Patent: US 8,017,322 B2
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/689 for bacteria
• CPC Class Codes: C12Q 2565/627 being a mass spectrometer
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers

Abstract

Method for detecting and identifying unknown bioagents, including bacteria, viruses and the like, by a combination of nucleic acid amplification and molecular weight determination using primers which hybridize to conserved sequence regions of nucleic acids derived from a bioagent and which bracket variable sequence regions that uniquely identify the bioagent. The result is a “base composition signature” (BCS) which is then matched against a database of base composition signatures, by which the bioagent is identified.

Claims

1. A method of preparing a database for use in identification of an organism comprising:

a) aligning a plurality of nucleic acid gene sequences of a plurality of organisms of known identity;

b) analyzing said plurality of sequences for regions of conservation;

c) identifying a plurality of primer binding sites within said regions of conservation for priming and obtaining one or more amplifiable regions within said plurality of sequences;

d) determining the base compositions of said one or more amplifiable regions for members of said plurality of known organisms wherein said base composition identifies the number of A residues, C residues, T residues, G residues, U residues, analogs thereof and mass tag residues thereof in said amplifiable region to obtain a plurality of base compositions of amplifiable regions indexed to the identity of one or more members of said plurality of organisms of known identity; and

e) populating a database with said base compositions and indexed identities of members of said plurality of organisms obtained in step d) wherein said database is not populated with nucleic acid sequences.

2. The method of claim 1 further comprising calculating the molecular masses of said amplifiable regions and indexing said molecular masses to said identities of members of said plurality of organisms.

3. The method of claim 1 wherein said organism is a bacterium, virus, fungus or protozoan.

4. The method of claim 1 wherein said nucleic acid sequences comprise at least one gene encoding ribosomal RNA or at least one gene encoding at least one protein that participates in translation, replication, recombination and repair, transcription, nucleotide metabolism, amino acid metabolism, lipid metabolism, energy generation or secretion.

5. The method of claim 4 wherein said at least one gene encoding said at least one protein encodes DNA polymerase, RNA polymerase, elongation factor Tu, heat shock protein groEL, phosphoglycerate kinase, NADH dehydrogenase, DNA ligase, DNA topoisomerase, or elongation factor G.

6. The method of claim 1 wherein said primer binding sites are 80% to 100% conserved among said aligned sequences of step a).

7. The method of claim 1 wherein the intervening region between said primer binding sites has no greater than 5% sequence identity among said aligned sequences of step a).

8. The method of claim 1 wherein said amplifiable regions are between 46 and 166 nucleobases in length.

9. The method of claim 1 wherein said database comprises 19 or more base compositions of amplifiable regions of nucleic acid, indexed to the identity of an organism.

10. The method of claim 1 wherein said identity is a genus name, a species name, or a strain name.